Cookies disclaimer

I agree Our site saves small pieces of text information (cookies) on your device in order to deliver better content and for statistical purposes. You can disable the usage of cookies by changing the settings of your browser. By browsing our website without changing the browser settings you grant us permission to store that information on your device.

The subjective decision of cessation of colorectal cancer screening

   229

The Lancet Gastroenterology & Hepatology - Colorectal cancer is the second most common cause of cancer death in men and women in the USA. Research has shown that colorectal cancer screening reduces associated incidence and mortality.

Regular testing is essential for good patient outcomes; approximately 90% of those diagnosed with early-stage colorectal cancer live for 5 years or more.

A group of American researchers pointed out the inconsistency of screening guidelines for patients older than 75 years, which could lead to over-screening or under-screening. They strongly suggest that colorectal cancer screening guidelines should be re-evaluated and revised to be evidence-based, objective, and consistent across organizations to provide tailored, appropriate care for all patients.

 

The subjective decision of cessation of colorectal cancer screening

 

Authors: Casey L Daniel, Danielle Keyes, Kelly Gilreath

The Lancet Gastroenterology & Hepatology, DOI: http://dx.doi.org/10.1016/S2468-1253(17)30254-6, October 2017

The subjective decision of cessation of colorectal cancer screening

Click here to read the full article 


Your browser is out-of-date!

Update your browser to view this website correctly. Update my browser now

×